SCHEMBL13136705

SCHEMBL13136705

CNCc1ccccc1CCC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.48
PTGER1 P34995 3/20 0.46
PTGER4 P35408 3/20 0.46
PTGER3 P43115 3/20 0.46
PTGER2 P43116 3/20 0.46
FFAR1 O14842 7/20 0.46
NPSR1 Q6W5P4 2/20 0.46
FFAR4 Q5NUL3 2/20 0.44
SLC6A3 Q01959 3/20 0.41
HDAC3 O15379 1/20 0.41
MAPK1 P28482 1/20 0.41
ADRA1A P35348 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL59198 0.84 KEAP1 (0.65) KEAP1PTGER1PTGER4PTGER3PTGER2
SCHEMBL11468455 0.81 AKR1B1 (0.55) SLC6A3ADRA1ASLC6A2SLC6A4KDM4E
SCHEMBL878984 0.80 KEAP1 (0.56) KEAP1PTGER1PTGER4PTGER3PTGER2
Hydrochloric Acid SCHEMBL11484601 0.79 AKR1B1 (0.53) SLC6A3ADRA1ASLC6A2SLC6A4KDM4E
Trifluoroacetic Acid SCHEMBL8007706 0.79 SLC6A2 (0.44) SLC6A3HDAC3MAPK1HDAC1SMN1; SMN2
SCHEMBL13136751 0.78 SLC6A4 (0.44) FFAR1NPSR1FFAR4SLC6A3HDAC6
SCHEMBL11263494 0.78 KEAP1 (0.48) KEAP1PTGER1PTGER4PTGER3PTGER2
SCHEMBL27458277 0.77 KEAP1 (0.63) KEAP1PTGER1PTGER4PTGER3PTGER2
Water SCHEMBL10936872 0.77 NPSR1 (0.59) KEAP1PTGER1PTGER4PTGER3PTGER2
SCHEMBL8016874 0.77 SLC6A4 (0.57) SLC6A3SLC6A2SLC6A4KDM4ECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230117680-A1 CYCLOPHILIN D INHIBITORS AND USES THEREOF THE BROAD INSTITUTE, INC. (US) 2023-04-20 US disclosed
US-20100222326-A1 New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders UCB PHARMA, S.A. (BE) 2010-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222326-A1 New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders CNR2, CNR1, SLC18A2 KEAP1 680/4885PTGER1 870/4885PTGER4 793/4885
US-20230117680-A1 CYCLOPHILIN D INHIBITORS AND USES THEREOF PPID, PPIF, PPIL1 KEAP1 445/4885PTGER1 818/4885PTGER4 2599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.